Emergent BioSolutions (United Kingdom)
Emergent BioSolutions Inc. is an American multinational specialty biopharmaceutical company headquartered in Gaithersburg, Maryland. It develops vaccines and antibody therapeutics for infectious diseases and opioid overdoses, and it provides medical devices for biodefense purposes. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Emergent BioSolutions (United Kingdom), United Kingdom, covering academic research published from 2000 to 2025. Read More.
Open Access Percentage
70%
Total
Publications
100
Total Open
Publications
70
Total
Citations
1.6K
Open Access
Percentage
70%
Total
Publications
100
Total Open
Publications
70
Total
Citations
1.6K
Breakdown
Publisher Open
27%
Both
33%
Other Platform Open
9%
Closed
31%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 49%
29
Hybrid 29%
17
No Guarantees 22%
13
Other Platform Open
Institution 69%
29
Domain 40%
17
Public 12%
5
Other Internet 12%
5
Preprint 7%
3
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 17 |
doaj.org OAI-PMH Repository | Institution | 13 |
University of Oxford | Institution | 4 |
DOI | Other Internet | 4 |
University of Birmingham | Institution | 2 |
University of Amsterdam | Institution | 2 |
The University of Melbourne | Institution | 2 |
Open Research Library | Public | 2 |
medRxiv | Preprint | 2 |
LA Referencia | Institution | 2 |